Endometrial Cancer

All Diseases

Introduction

Endometrial cancer starts in the lining of the uterus (the endometrium). It is the most common type of uterine cancer and is usually an adenocarcinoma. Less common uterine cancers, such as uterine sarcomas, arise from other uterine tissues.

Postmenopausal vaginal bleeding is the classic warning sign and should always be evaluated. Premenopausal people may notice bleeding between periods, unusually heavy bleeding, or abnormal watery or blood-tinged discharge.

Risk rises when estrogen exposure to the endometrium is relatively high without enough opposing progesterone—links include obesity, longer lifetime menstruation, never having been pregnant, and certain hormone therapies. Inherited Lynch syndrome (HNPCC) also elevates risk.

This page covers symptoms, risk factors, diagnosis, staging, treatment options, prevention ideas, complications, and when to seek care. It is general education—oncology and gynecology teams personalize plans.

Overview

Most endometrial cancers are found at an early stage because abnormal bleeding prompts investigation. Pelvic exam, ultrasound, hysteroscopy, and endometrial biopsy are typical steps.

Staging describes whether disease is confined to the uterus or has spread to cervix, pelvic nodes, or distant organs. Final stage often incorporates surgical findings.

Treatment frequently includes hysterectomy with removal of tubes and ovaries, with radiation, chemotherapy, or hormone therapy added based on stage, grade, and health status.

  • Cancer of the uterine lining (endometrium)
  • Usually adenocarcinoma; sarcomas are less common
  • Postmenopausal bleeding is a key red flag
  • Estrogen–progesterone imbalance and obesity are major risk themes
  • Biopsy confirms the diagnosis; imaging and surgery refine stage
  • Surgery is central for many early cases; other modalities for advanced disease
  • Lynch syndrome raises hereditary risk

What happens in the body

Estrogen stimulates endometrial growth. When progesterone opposition is inadequate over years, atypical hyperplasia can progress to invasive carcinoma in some people.

Tumor cells may then invade the myometrium, travel to pelvic lymph nodes, or spread to distant sites. Understanding hormone receptor status and histologic type guides systemic therapy choices.

  • Unopposed estrogen → endometrial overgrowth
  • Progression from hyperplasia to carcinoma in a subset
  • Local invasion into uterine muscle
  • Possible lymphatic and distant metastasis
  • Obesity increases peripheral estrogen conversion

Signs and symptoms

Report these symptoms promptly—especially after menopause:

  • Any vaginal bleeding after menopause
  • Bleeding between menstrual periods
  • Unusually heavy or prolonged periods
  • Watery, pink, or blood-tinged vaginal discharge
  • Pelvic pain or pressure
  • Pain during sex
  • Unexplained pelvic mass symptoms in later disease

Causes and risk factors

Exact triggers vary; these factors raise likelihood:

  • Hormone patterns with excess estrogen relative to progesterone
  • Early menarche or late menopause (more lifetime menstrual cycles)
  • Never having been pregnant
  • Older age, especially after menopause
  • Obesity altering hormone balance
  • Hormone therapy for breast cancer that stimulates the endometrium (discuss drug-specific risks with your oncology team)
  • Lynch syndrome / hereditary nonpolyposis colorectal cancer (HNPCC)
  • Prior endometrial hyperplasia
  • Certain estrogen-only regimens without adequate progestin when a uterus is present

Diagnosis and evaluation

Abnormal bleeding needs a clear explanation—evaluation is stepwise:

  • Pelvic examination
  • Transvaginal ultrasound to assess endometrial thickness and uterine structure
  • Hysteroscopy to view the cavity directly
  • Endometrial biopsy
  • Dilation and curettage or operative sampling when office biopsy is inconclusive
  • Chest imaging, CT, PET, or blood tests for staging as indicated
  • Surgical staging with lymph-node assessment when appropriate

Treatment and management

Plans depend on stage, grade, fertility goals, and overall health:

  • Hysterectomy (removal of the uterus), often with bilateral salpingo-oophorectomy
  • Lymph-node evaluation during surgery to refine stage
  • External-beam radiation to reduce local recurrence risk in selected cases
  • Brachytherapy (internal vaginal radiation) when indicated
  • Preoperative radiation occasionally to shrink tumor before surgery
  • Radiation alone when surgery is not safe
  • Hormone therapy (progestins or estrogen-lowering strategies) for selected advanced or recurrent disease
  • Chemotherapy for advanced or recurrent cancer beyond the uterus
  • Palliative radiation to help control pain in advanced disease
  • Genetic counseling when Lynch syndrome is suspected

Prevention, self-care, and lifestyle

Not every condition is fully preventable, but the steps below may lower risk or recurrence:

  • Maintain a healthy weight and stay physically active
  • Discuss risks of unopposed estrogen if you still have a uterus
  • Report postmenopausal bleeding immediately—early detection saves lives
  • Ask about Lynch syndrome screening if colorectal or endometrial cancers run in the family
  • Manage diabetes and metabolic health
  • Keep routine gynecologic follow-up, especially if using tamoxifen or related therapies

Possible complications

Delay, missed care, or unsafe self-medication can raise the chance of complications in some cases:

  • Spread to cervix, lymph nodes, or distant organs
  • Treatment-related menopause after ovary removal
  • Radiation side effects on bowel or bladder
  • Chemotherapy toxicity
  • Recurrence after initial therapy
  • Infertility after hysterectomy
  • Emotional distress and quality-of-life impact

When to see a doctor or seek emergency care

Seek prompt medical advice or emergency care if any of the following apply—it is safer not to wait and see:

  • Any bleeding after menopause
  • Persistent intermenstrual bleeding or abnormal discharge
  • Pelvic pain with abnormal bleeding
  • Known Lynch syndrome with new gynecologic symptoms
  • Post-treatment warning signs your oncology team listed for recurrence

Living with the condition

Keep a bleeding diary before diagnosis and report changes after treatment.

Ask about bone, heart, and sexual-health support if early menopause is induced.

Survivorship visits and imaging schedules matter even when you feel well.

Frequently asked questions

Is endometrial cancer the same as cervical cancer?

No. Endometrial cancer starts in the uterine lining; cervical cancer starts in the cervix. Screening Pap tests detect cervical changes, not endometrial cancer.

Does postmenopausal bleeding always mean cancer?

No, but it always needs evaluation. Many causes are benign, yet cancer must be ruled out promptly.

What are the stages?

Broadly: Stage I uterus only; Stage II involves cervix; Stage III beyond uterus but not bladder/rectum (nodes may be involved); Stage IV spread to bladder, rectum, or distant sites.

Is surgery always required?

Surgery is standard for many medically fit patients with early disease. Radiation, hormones, or chemotherapy may be primary or added options when surgery is unsafe or disease is advanced.

Can lifestyle changes help?

Healthy weight, activity, and metabolic care lower risk and support recovery, but they do not replace guideline treatment for diagnosed cancer.

Should my family be tested?

If Lynch syndrome or multiple related cancers are present, genetic counseling for relatives is appropriate.

Important caution

This article is for general health education only. It is not a personal diagnosis or prescription.

Postmenopausal bleeding or persistent abnormal bleeding deserves prompt gynecologic evaluation.

Early-stage disease is often highly treatable with surgery and tailored adjuvant care.